Solara Active Pharma Sciences Limited has informed the Exchange about the revised Intimation of Schedule of Analyst / Institutional Investor call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, to be held on Friday, February 06, 2026 at 3:30 P.M. to discuss the Company's unaudited financial results for the quarter ended December 31, 2025